Jenny Morgenweck is a Program Manager for the Genetic Resource Science group and works in the operations of the Rare and Orphan Disease Center at The Jackson Laboratory (JAX). Her responsibilities include coordinating various efforts across JAX in addition to working with patient foundations in the development of novel mouse models for the study of rare disease. Dr. Morgenweck has over 10 years of experience in behavioral and physiological phenotyping, in addition to novel therapeutic compound development targeting mouse models of inflammatory and neuropathic pain.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.